INmune Bio Inc. (INMB)
NASDAQ: INMB · Real-Time Price · USD
1.310
-0.020 (-1.50%)
At close: Mar 9, 2026, 4:00 PM EDT
1.300
-0.010 (-0.76%)
After-hours: Mar 9, 2026, 6:11 PM EDT
INmune Bio Market Cap
INmune Bio has a market cap or net worth of $35.09 million as of March 9, 2026. Its market cap has decreased by -82.59% in one year.
Market Cap
35.09M
Enterprise Value
9.50M
1-Year Change
-82.59%
Ranking
Category
Stock Price
$1.31
Market Cap Chart
Since February 4, 2019, INmune Bio's market cap has decreased from $77.82M to $35.09M, a decrease of -54.91%. That is a compound annual growth rate of -10.63%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sensei Biotherapeutics | 37.96M |
| Actinium Pharmaceuticals | 37.44M |
| Atara Biotherapeutics | 37.28M |
| Lisata Therapeutics | 36.87M |
| Tvardi Therapeutics | 36.87M |
| PDS Biotechnology | 36.82M |
| NovaBay Pharmaceuticals | 36.31M |
| Celularity | 34.89M |